BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic steatohepatitis
1
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 14 | Download: 32
2
Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
12/5/2025 11:28:02 AM | Browse: 50 | Download: 112
3
Pathological features of non-alcoholic steatohepatitis in a pediatric patient with heterozygous familial hypobetalipoproteinemia: A case report
2/20/2025 8:39:54 AM | Browse: 149 | Download: 548
4
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 164 | Download: 687
5
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
10/25/2024 3:02:15 AM | Browse: 166 | Download: 629
6
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
12/27/2023 5:42:53 AM | Browse: 302 | Download: 1124
7
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 399 | Download: 1200
8
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
3/28/2023 12:59:29 PM | Browse: 347 | Download: 875
9
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
3/22/2023 11:20:34 AM | Browse: 419 | Download: 1382
10
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
3/17/2023 6:20:53 AM | Browse: 408 | Download: 1162
11
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
1/6/2023 2:52:58 AM | Browse: 450 | Download: 929
12
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
1/6/2023 2:52:58 AM | Browse: 447 | Download: 1148
13
Management of metabolic-associated fatty liver disease: The diabetology perspective
1/4/2023 5:53:02 AM | Browse: 448 | Download: 1007
14
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
1/4/2023 5:53:01 AM | Browse: 445 | Download: 1352
15
Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease
10/28/2022 7:46:25 AM | Browse: 594 | Download: 1863
16
Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study
9/23/2022 12:48:56 AM | Browse: 616 | Download: 1942
17
Nonalcoholic fatty liver disease and diabetes
9/9/2022 3:45:24 PM | Browse: 710 | Download: 1675
18
Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
8/26/2022 9:51:35 AM | Browse: 609 | Download: 1661
19
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
5/24/2022 10:35:19 AM | Browse: 680 | Download: 1613
20
Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
2/22/2022 9:25:37 AM | Browse: 724 | Download: 1761
21
Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
12/27/2021 5:24:01 AM | Browse: 734 | Download: 2037
22
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
11/24/2021 9:54:22 AM | Browse: 689 | Download: 1779
23
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 919 | Download: 2009
24
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 721 | Download: 2064
25
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
4/29/2021 2:12:02 AM | Browse: 827 | Download: 1929
26
Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs
2/25/2021 3:45:30 PM | Browse: 758 | Download: 1969
27
Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
1/25/2021 6:05:27 AM | Browse: 716 | Download: 1956
28
Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
12/14/2020 8:10:05 AM | Browse: 961 | Download: 2464
29
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 1132 | Download: 2174
30
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
10/24/2020 2:27:20 AM | Browse: 1021 | Download: 2139
31
Role of betaine in liver disease-worth revisiting or has the die been cast?
10/14/2020 11:33:23 AM | Browse: 888 | Download: 1973
32
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 764 | Download: 2562
33
Management of nonalcoholic fatty liver disease in the Middle East
7/7/2020 2:50:53 PM | Browse: 1025 | Download: 1770
34
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
6/19/2020 9:46:52 AM | Browse: 1159 | Download: 2360
35
Natural products that target macrophages in treating non-alcoholic steatohepatitis
5/14/2020 3:43:04 AM | Browse: 1137 | Download: 2083
36
L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis
2/28/2020 10:08:51 AM | Browse: 1344 | Download: 2346
37
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
9/7/2019 4:43:36 AM | Browse: 1157 | Download: 2477
38
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 1303 | Download: 2493
39
Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
5/28/2019 9:29:42 AM | Browse: 1229 | Download: 2809
40
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1397 | Download: 2246
41
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 1163 | Download: 1805
42
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 1418 | Download: 2634
43
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 1114 | Download: 1852
44
Current status of imaging in nonalcoholic fatty liver disease
8/27/2018 12:43:23 PM | Browse: 1480 | Download: 1836
45
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 1312 | Download: 1707
46
Apoptosis and non-alcoholic fatty liver diseases
7/5/2018 1:33:43 AM | Browse: 1357 | Download: 2091
47
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 1449 | Download: 2821
48
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 1081 | Download: 1727
49
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 1512 | Download: 1834
50
Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
4/19/2018 7:56:07 AM | Browse: 1657 | Download: 2546